| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.06 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.07 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |